5 References

  • 1
    Mendis, S., Puska, P., Norrving, B., (Eds.), Global Atlas on Cardiovascular Disease Prevention and Control, World Health Organization, Geneva 2011.
  • 2
    Kris-Etherton, P. M., Etherton, T. D., Carlson, J., Gardner, C., Recent discoveries in inclusive food-based approaches and dietary patterns for reduction in risk for cardiovascular disease. Curr. Opin. Lipidol. 2002, 13, 397407.
  • 3
    Boushey, C. J., Beresford, S. A. A., Omenn, G. S., Mutulsky, A. G. et al., A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995, 274, 10491057.
  • 4
    Verhaar, M. C., Stroes, E., Rabelink, T. J., Folates and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 613.
  • 5
    McNulty, H., Pentieva, K., Hoey, L. Ward, M., Homocysteine, B vitamins and CVD. Proc. Nutr. Soc. 2008, 67, 232237.
  • 6
    Mudd, S. H., Skovby, F., Levy, H. L., Pettigrew, K. D., The natural history of homocystinuria due to cystathione-B-synthase deficiency. Am. J. Hum. Genet. 1985, 37, 131.
  • 7
    Splaver, A., Lamas, G. A., Hennekens, C. H., Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology and the need for randomised trials. Am. Heart J. 2004, 148, 3440.
  • 8
    Voutilainen, S., Lakka, T. A., Porkkala-Sarataho, E., Rissanen, T. et al., Low serum folate concentrations are associated with an excess incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Eur. J. Clin. Nutr. 2000, 54, 424428.
  • 9
    Voutilainen, S., Virtanen, J. K., Rissanen, T. H. Alfthan, G. et al., Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am. J. Clin. Nutr. 2004, 80, 317323.
  • 10
    Durga, J., Bots, M. L., Schouten, E. G., Kok, F. J., Low concentrations of folate not hyperhomocysteinemia are associated with carotid intima-media thickness. Atherosclerosis 2005, 179, 285292.
  • 11
    Mangoni, A. A., Sherwood, R. A., Asonganyi, B., Swift, C. G. Short-term folic oral acid supplementation enhances endothelial function in patients with type 2 diabetes. Am. J. Hypertens. 2005, 81, 220226.
  • 12
    Tawakol, A., Migrino, R. Q., Aziz, K. S., Waitkowska, J. et al., High dose folic acid acutely improves coronary vasodilator functions in patients with coronary artery disease. J. Am. Coll. Cardiol. 2005, 45, 15801584.
  • 13
    Till, U., Rohl, P., Jentsch, A., Till, H., Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, vitamins B6 and B12. Atherosclerosis 2005, 181, 131135.
  • 14
    Lohn, M., Dubrovska, G., Lauterbach, B., Luft, F. C. et al., Periadventitial fat releases a vascular relaxing factor. FASEB J. 2002, 16, 10571063.
  • 15
    Barandier, C., Montani, J.-P., Yang, Z., Mature adiposites and perivasuclar adipose tissue stimulate vascular smooth muscle cell proliferation: effects of ageing and obesity. Am. J. Physiol. Heart Circ. Physiol. 2005, 289, H1807H1813.
  • 16
    Wang, H., Jiang, X.-H., Yang, F., Gaubatx, J. W. et al., Hyperhomocysteinemia accelerates atherosclerosis and cystathionine b-synthase and apolipoprotein E double knockout mice with and without dietary perturbation. Blood 2003, 101, 39013907.
  • 17
    Namekata, K., Enokido, Y., Ishi, I., Nagai, Y. et al., Abnormal lipid metabolism in cystathionine B-synthase-deficient mice, and animal model for hyperhomocysteinemia. J. Biol. Chem. 2004, 279, 5296152969.
  • 18
    Mikael, L. G., Genest, J., Rozen, R. Elevated homocysteine reduces apolipoprotein A-1 expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ. Res. 2006, 98, 564571.
  • 19
    Devlin, A. M., Singh, R., Wade, R. E., Innis, S. M. et al., Hypermethylation of Fads2 and altered hepatic fatty acid and phospholipid metabolism in mice with hyperhomocysteinemia. J. Biol. Chem. 2007, 282, 3708237090.
  • 20
    Zhang, S. H., Reddick, R. L., Piedrahita, J. A., Maeda, N., Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468471.
  • 21
    McNeil, C. J., Beattie, J. H., Gordon, M.-J., Pirie, L. P. et al., Differential effects of nutritional folic acid deficiency and moderate hyperhomocysteinemia on aortic plaque formation and genome-wide DNA methylation in vascular tissue from ApoE -/- mice. Clin. Epigenet. 2011, 2, 361368.
  • 22
    Duthie, S. J., Grant, G., Pirie, L. P., Watson, A. J. et al., Folate deficiency alters hepatic and colon MGMT and OGG-1 DNA repair protein expression in rats but has no effect on genome-wide DNA methylation. Cancer Prev. Res. 2010, 3, 92100.
  • 23
    Beattie, J. H., Duthie, S. J., Kwunm, I.-S., Ha, T.-Y., Rapid quantification of aortic lesions in ApoE -/- mice. J. Vasc. Res. 2009, 46, 347352.
  • 24
    Wang, W., Kramer, P. M., Yang, S., Pereira, M. A., et al., Reversed-phase high performance liquid chromatography procedure for the simultaneous determination of S-adenosyl-L-methionine and S-adenosyl-L-homocysteine in mouse liver and the effect of methionine on their concentrations. J. Chromatogr. B 2001, 762, 5965.
  • 25
    Folsch, J., Less, M., Sloane Stanley, G. H., A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226, 497509.
  • 26
    Burdge, G. C., Wright, P., Jones, A. E., Wooton, S. A., A method for the separation of phosphatidylcholine and tri-acylglycerol, non-esterified fatty acids and cholesterol seters from plasma by solid-phase extraction. B. J. Nutr. 2000, 84, 781787.
  • 27
    Wilcken, D. E. L., in: Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D. et al. (Eds.), The Metabolic and Molecular Basis of Inherited Disease. 8th Edn., McGraw Hill, New York, pp. 39873933.
  • 28
    Burke, A. P., Fonseca, V., Kolodgie, F., Zieske, A. et al., Increased serum homocysteine and sudden death resulting from coronary atherosclerosis with fibrous plaques. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 19361941.
  • 29
    Wilson, K. M., McCaw, R. B., Leo, L., Arning, E. et al., Prothrombotic effects of hyperhomocysteinemia and hypercholesterolemia in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 233240.
  • 30
    Zhou, J., Werstruck, G. H., Lhotak, S., Shi, Y. Y. et al., Hyperhomocystenemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice. FASEB J. 2008, 22, 25692578.
  • 31
    Carnicer, R., Navarro, M. A., Arbones-Mainar, J. M., Acin, S. et al., Folic acid supplementation delays atherosclerotic lesion development in ApoE-deficient mice. Life Sci. 2007, 80, 638643.
  • 32
    Werstruck, G. H., Lentz, R. S., Dayal, S., Hossain, G. S. et al., Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 2001, 107, 12631273.
  • 33
    Chen, Z., Karaplis, A. C., Ackerman, S. L. Pogribny, I. P. et al., Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 2001, 10, 433443
  • 34
    Dong, C., Yoon, W., Goldschmidt-Clermont, P. J., DNA methylation and atherosclerosis. J. Nutr. 2002, 132, 2406S2409S.
  • 35
    Zaina, S., Lindholm, M. W., Lund, G., Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocystenemia? J. Nutr. 2005, 153, 58.
  • 36
    Turunen, M. P., Aavik, E., Yla-Herttula, S., Epigenetics and atherosclerosis. Biochim. Biophys. Acta. 2009, 1790, 886891.